Delivery Order SPE2DB20D1100-SPE2DB25FE1QQ
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $20,588.83 for SKYRIZI 150 mg/mL pen injectors on July 14, 2025, with completion scheduled for July 15, 2025. This firm fixed-price contract, which received no set-aside designation, represents a competitive award to the major pharmaceutical distributor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the...
- The Defense Logistics Agency awarded a $52,711.33 delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of SKYRIZI 150 mg/mL pen injections, with final delivery required by August 28, 2025. This competitively awarded contract utilizes firm fixed-price pricing and carries no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement needs across the Defense Health...
- The Defense Logistics Agency awarded a $59,150 firm fixed-price delivery order to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/ml pen injectors, with an ultimate completion date of August 28, 2025. This non-set-aside competitive award was issued on August 27, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. As a child delivery order under a larger indefinite delivery contract vehicle, this award represents a tactical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order contract valued at $34,595.45 to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/mL pen injections on September 16, 2025. The contract utilizes a firm fixed price delivery order structure with no set-aside designation, indicating it was competitively awarded. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery at its corporate office location. This order falls under...
- The Defense Logistics Agency awarded a delivery order valued at $53,327.86 to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/mL pen prefilled syringes. This firm fixed-price, competitively awarded contract was issued on August 21, 2025, with an ultimate completion date of August 22, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. No set-aside designation was applied to this award, indicating open competition among...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of SKYRIZI 150 mg/ml pens with a ceiling value of $16,459.82. This firm fixed price delivery order, which completes on August 26, 2025, represents a non-set-aside competitive award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency has awarded a delivery order valued at $40,155.43 to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/ml pen injectors, with an ultimate completion date of September 3, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside transaction executed on September 2, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, with extensive experience...
- The Defense Logistics Agency awarded a $25,899.93 firm fixed price delivery order to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/mL pen injectors, with an ultimate completion date of July 14, 2025. This competitively awarded, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The delivery location is AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $71,674.48 to AmerisourceBergen Drug Corp for SKYRIZI 150 MG/ML pen injectors on September 8, 2025, with completion scheduled for September 9, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen, headquartered in...
- The Defense Logistics Agency awarded a $16,496.83 firm fixed-price delivery order to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/mL pen injectors, with an ultimate completion date of June 18, 2025. This non-set-aside competitive award leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle running through December 2026. The product will be delivered to the company's corporate office...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE1QQDelivery Order
The Defense Logistics Agency awarded a delivery order valued at approximately $77.4K to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/ml pen injections, with a completion deadline of September 30, 2025. This non-set-aside competitive award reflects AmerisourceBergen's established role as a critical pharmaceutical distributor supporting federal medical procurement requirements. The delivery order will be performed at the company's corporate headquarters in Conshohocken, Pennsylvania, utilizing firm fixed pricing under a standard delivery order contract type. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion comprehensive pharmaceutical support vehicle extending through December 2026. The IDC enables the company to supply a diverse portfolio of pharmaceutical products and medical supplies to military healthcare systems and other federal agencies, including the Defense Health Agency and U.S. Coast Guard. SKYRIZI, a biologic immunosuppressant, aligns with AmerisourceBergen's extensive track record of delivering specialty medications and brand-name pharmaceuticals across multiple therapeutic domains to support federal military and veteran healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $77.4k | 9/29/25 |